Edmund Pasimio, MD
Physical Medicine & Rehabilitation · Las Vegas, NVNPI 1114015229
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,422 and has fallen 73.5% since, to $377 in 2025. Among physical medicine & rehabilitation clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Forte Bio-pharma LLC$936
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$915
- Collegium Pharmaceutical, Inc.$843
- AbbVie$728
- Scilex Pharmaceuticals Inc.$420
- Amgen$369
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,433100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Forte Bio-pharma LLC | 15 | $936 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 49 | $915 |
| Collegium Pharmaceutical, Inc. | 49 | $843 |
| AbbVie(2 entities) | 37 | $728 |
| Scilex Pharmaceuticals Inc. | 28 | $420 |
| Amgen | 16 | $369 |
| AstraZeneca | 2 | $245 |
| Zyla Life Sciences, Inc. | 33 | $216 |
| Daiichi Sankyo Inc. | 16 | $213 |
| Johnson & Johnson | 1 | $150 |
| Pfizer | 6 | $143 |
| Esperion Therapeutics, Inc. | 1 | $130 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $125 |
| Lundbeck LLC | 5 | $118 |
| Biodelivery Sciences International, Inc. | 6 | $118 |
| Assertio Therapeutics, Inc. | 6 | $84 |
| Novartis | 5 | $66 |
| Tersera Therapeutics LLC | 4 | $60 |
| Sentynl Therapeutics, Inc. | 4 | $59 |
| Protega Pharmaceutials Inc | 3 | $51 |
| IBSA Pharma Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Impel Pharmaceuticals Inc. | 2 | $46 |
| Lilly USA, LLC | 3 | $43 |
| Boston Scientific | 3 | $41 |
| Redhill Biopharma Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Bioventus LLC | 1 | $26 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| USWM, LLC | 1 | $21 |
| Promius Pharma LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,433 in reported general payments places this provider in the 90th percentile of 98 physical medicine & rehabilitation providers in Nevada.
See all physical medicine & rehabilitation providers in Nevada →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 243 | $49,497 |
| Xtampza ErOxycodone Myristate | 81 | $42,875 |
| RelistorMethylnaltrexone Bromide | 13 | $40,962 |
| Oxycodone Hcl | 542 | $12,998 |
| Naloxone Hcl | 116 | $8,608 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 230 | $7,366 |
| LinzessLinaclotide | 12 | $6,421 |
| MovantikNaloxegol Oxalate | 18 | $6,019 |
| Morphine Sulfate ErMorphine Sulfate | 320 | $5,609 |
| Diclofenac Sodium | 22 | $4,537 |
| Lidocaine | 43 | $2,502 |
| Tizanidine Hcl | 362 | $2,056 |
| Gabapentin | 323 | $2,041 |
| Morphine Sulfate | 39 | $1,250 |
| Baclofen | 127 | $1,219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $843 | $42,87581 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $915 | $40,96213 claims |
| AbbVieLinzess | $728 | $6,42112 claims |
| Redhill Biopharma Inc.Movantik | $37 | $6,01918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 98 physical medicine & rehabilitation providers in Nevada.
Other physical medicine & rehabilitation in Las Vegas
- Kyle WentzLas Vegas$8K
- Daniel KrauchukLas Vegas$6K
- David OliveriLas Vegas$3K
- William MendanhaLas Vegas$3K
- Roberto ChuapocoLas Vegas$2K
- Se Won LeeLas Vegas$958
- Jeffrey FarringtonLas Vegas$903
- Adrian DavoodianLas Vegas$667
- Paul SchwinglerLas Vegas$479
- Benjamin HaightLas Vegas$474
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.